Yes uplisting should be a priority, however they need all the requirements to be able to do it. The meet about everything except the share price. So they need to keep working on their acquisitions and revenue to help drive the share price up. It may still take some time for them to do that, however when revenue numbers start being seen, and net profits posted, then the share price should go up.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.